Annual Urology Advocacy Summit (2022)

Washington, DC US
March 14, 2022 to March 16, 2022

Don't miss this year’s in-person AUA Summit!
March 14-16, 2022

Make plans now to join the urology community in Washington, DC for the 5th Annual Urology Advocacy Summit, which is an event designed to expand, strengthen and unify the voice of urology on policy matters impacting our practices and patients. As always, we will be engaging Sections, urologic specialty organizations and patient advocacy organizations alike – and we hope you will be among them!

The dynamic conference will feature two days of in-person educational and trending policy sessions with an opportunity for attendees to earn continuing medical education credits. It also will include a day of Capitol Hill meetings. The event will leave participants feeling empowered and well-versed in advocating for policy matters that impact our practices, patients and the future of urology.

Target Audience

  • young urologists
  • researchers
  • subspecialties
  • nurses
  • nurse practitioners
  • physician assistants
  • residents
  • fellows and medical students
  • patient advocates

Learning Objectives

After completing this activity, participants will be able to:

  • Deceptive and Fraudulent Marketing in Urology
    • Discuss the amount of fraudulent advertising of supplements, especially in sexual function and dysfunction.
    • Outline steps from a legislative perspective to protect the public health.
  • Physician Payment
    • Describe the CMS implemented significant policy changes in the CY 2022 PFS final rule.
    • Describe advocacy issues that legislators need to know to develop permanent fixes to Medicare payment.
  • Growing the Specialty Physician Workforce
    • Explain and identify legislation to address the overall topic of urologist shortages – particularly in rural areas of the country.
    • Describe the growing concern for Medicare beneficiaries in rural America with regard to the aging urologic workforce and increased centralization of urologists in larger cities.
  • Telehealth
    • Discuss specific recommendations the AUA and urologic community can use to expand telemedicine.
  • Research Advocacy
    • Explain and discuss how urologists can support education, outreach and recruitment for clinical trials for diseases which disproportionately impact underrepresented populations.
  • What to Watch 2022: State Advocacy Update
    • Explain the Scope of Practice, Interstate Medical Licensure Compact, and other hot-button issues in 2022 and how they impact urologic practice
  • CPT/RUC 101 and Why It Matters
    • Discuss the CPT/RUC process – specifically the RUC survey process and why it is critical to ensure the appropriate valuation of urology codes by CMS.
  • Utilization Management Tools: Barriers to Care
    • Outline utilization management tools that impede patient access to care.
    • Discuss the role of step therapy and prior authorization, its impact on personalized medicine, and its barriers to care and physician treatment.
Course summary
Available credit: 
  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Non-Physician Participation
Course opens: 
Course expires: 
Event starts: 
03/14/2022 - 6:00am EDT
Event ends: 
03/16/2022 - 11:59pm EDT

Please visit the meeting website to view the agenda

Hyatt Regency Washington on Capitol Hill
400 New Jersey Avenue NW
Washington, DC 20001
United States

Thank you to the following individuals for participating as planners and/or faculty in the accredited portion of this activity.

Juan J. Andino, MD, MBA; Robert A. Bass, MD, MBA; Tudor Borza, MD, MS; Chandra Clark; Jacqueline Collie; Brian D. Duty, MD; Mark T. Edney, MD, MBA; Mark Gibbons; Michael Hsieh, MD, PhD; Jason Humbert; Brian H. Irwin, MD; Illy Jaffer; Jonathan P. Jarow, MD; Deepak Kapoor, MD; Matthew C. Kincade, MD; Barry A. Kogan, MD; Tracey L. Krupski, MD; Bryan Lewis; Ali Manson; Randall B. Meacham, MD; Jay A.  Motola, MD; Amanda C. North, MD; Ally Perleoni; Gail S. Prins, PhD; Terrence C. Regan, MD; Eugene Rhee, MD, MBA; Jonathan N. Rubenstein, MD; Megan Thompson; Hossein Sadeghi-Nejad,MD;  Ira D. Sharlip, MD; Aaron Spitz, MD; Thomas Turk, MD; Jacqueline Zarro, PhD

Note: The educational content provided in this activity is non-clinical.  In accordance with the ACMCE Standards for Integrity and Independence in Accredited Continuing Education, the AUA is not required to identify, mitigate or disclose relevant financial relationships for activities that are non-clinical in nature.

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this live activity for a maximum of 5.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:
•    Peer review for valid, evidence-based content by the AUA COI Review Work Group. 
•    Attestation that clinical recommendations are evidence-based and free of commercial bias.
•    Introduction of a debate format (point-counterpoint)
•    Inclusion of moderated panel discussion with unbiased moderator
•    Publication of a parallel or rebuttal article for an article that is felt to be biased
•    Divestiture of the relationship by faculty
•    Recusal from controlling relevant aspects of planning 
•    Selection of alternative faculty for specific topic

Disclosure Policy Exceptions: In accordance with the ACMCE Standards for Integrity and Independence in Accredited Continuing Education, the AUA is not required to identify, mitigate or disclose relevant financial relationships for any of the activities:
•   Accredited education that is non-clinical.
•   Accredited education where the learner group is in control of content, such as a spontaneous case conversation among peers.
•   Accredited self-directed education where the learner controls their educational goals and reports on changes that resulted.

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.


Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.


Available Credit

  • 5.50 AMA PRA Category 1 Credit™
  • 5.50 Non-Physician Participation
Please login or register to take this course.

Attendees, please click "Take Course" to complete the evaluation, claim credit and print certificate.